Baxter International (NYSE:BAX) Updates Q1 2025 Earnings Guidance

Baxter International (NYSE:BAX) issued an update on its first quarter 2025 earnings guidance on Thursday morning. The company provided earnings per share guidance of 0.470-0.500 for the period, compared to the consensus earnings per share estimate of 0.490. The company issued revenue guidance of $3.7 billion-$3.7 billion, compared to the consensus revenue estimate of $2.6 billion. Baxter International also updated its FY 2025 guidance to 2.450-2.550 EPS.

Analyst Ratings Changes

Several equities research analysts recently commented on BAX shares. Stifel Nicolaus dropped their target price on Baxter International from $46.00 to $38.00 and set a “buy” rating on the stock in a report on Monday, November 11th. StockNews.com cut shares of Baxter International from a “buy” rating to a “hold” rating in a research report on Monday, November 11th. Citigroup dropped their price target on shares of Baxter International from $37.00 to $35.00 and set a “neutral” rating on the stock in a research note on Wednesday, December 11th. Finally, Barclays began coverage on shares of Baxter International in a research report on Thursday. They issued an “overweight” rating and a $39.00 price objective for the company. One analyst has rated the stock with a sell rating, seven have given a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $39.40.

Baxter International Stock Up 8.6 %

NYSE:BAX traded up $2.66 on Thursday, hitting $33.48. 5,642,260 shares of the company’s stock traded hands, compared to its average volume of 4,689,840. The firm has a 50-day moving average price of $30.52 and a 200-day moving average price of $34.15. The company has a current ratio of 1.43, a quick ratio of 1.09 and a debt-to-equity ratio of 1.31. The company has a market cap of $17.09 billion, a PE ratio of 166.95, a price-to-earnings-growth ratio of 9.95 and a beta of 0.61. Baxter International has a 1 year low of $28.33 and a 1 year high of $44.01.

Baxter International (NYSE:BAX) last posted its quarterly earnings results on Thursday, February 20th. The medical instruments supplier reported $0.58 earnings per share for the quarter, topping analysts’ consensus estimates of $0.52 by $0.06. Baxter International had a net margin of 0.77% and a return on equity of 18.30%. Equities analysts anticipate that Baxter International will post 1.83 EPS for the current fiscal year.

Baxter International Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 1st. Stockholders of record on Friday, February 28th will be issued a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a dividend yield of 2.03%. The ex-dividend date is Friday, February 28th. Baxter International’s dividend payout ratio is 340.02%.

About Baxter International

Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.